Delivery Order SPE2DB20D1050-SPE2DB24FH73G
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,478.05, is for the supply of Estradiol 0.01% Cream, a medication used in the treatment of certain medical conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Estradiol 0.01% cream. The contract has a firm fixed price of $1,552.80 and a period of performance through April 29, 2025. The award is not associated with a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to the DLA,...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) for the supply of Estradiol 0.01% cream. The contract has a ceiling value of $1,708.33 and a period of performance through April 3, 2023. Amerisourcebergen, a major pharmaceutical distributor, has a significant IDC with DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of pharmaceutical products and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Estradiol 0.01% cream in a 42.5 gram size. The firm-fixed-price contract has a ceiling value of $2,978.04 and is set to expire on September 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this order as a part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Estrace 0.01% Cream in 42.5 gram units. The contract has a firm fixed price, with a ceiling value of $1,249.26, and an ultimate completion date of July 10, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award to Amerisourcebergen Drug Corp from the Defense Logistics Agency (DLA) is for the delivery of Estradiol 0.01% Cream, 42.5 grams, valued at $1,169.99. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is a $999,999,999 contract running through November 2026. This IDC serves as a primary vehicle for the company to provide a broad range of pharmaceutical products and...
- This contract award to AmerisourceBergen Drug Corp is for the delivery of Estradiol 0.01% cream, a pharmaceutical product, to support federal government healthcare programs. The $2,561.18 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 7, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through...
- This federal contract award, SPE2DB22D3004|SPE2DB25FPV52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estradiol 0.01% Cream, a pharmaceutical product, with a ceiling value of $2,724.46. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 11, 2025. Amerisourcebergen holds a significant...
- This federal contract award, with identification number SPE2DB20D3101|SPE2DB24FRAT8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,536.84 delivery order is for the supply of Estradiol 0.01% Cream, 42.5 grams, with a completion date of February 6, 2024. This contract is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Estradiol 0.01% Cream, 42.5g, to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract, valued at $15,774.09, is a firm fixed-price delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 and runs through December 2025. This IDC...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB24FH73GDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Estradiol 0.01% cream. The contract has a firm fixed price of $1,048.62 and an ultimate completion date of June 18, 2024. It is not designated as a set-aside contract. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 6/17/24 |